MY ACCOUNT | NEWSLETTER |

History does not repeat itself but there are often parallels


In September 2018, former President Trump, happily tweeting because the S&P 500 had reached 3,000, was also angry with the Federal Reserve for continuing to raise interest rates. Even then, there had been an inflationary flare that the U.S. central bank had decided to address. And, even then, the rise in interest rates — less rapid than today — had caused a drop in both equity and bond markets. 

2018 was one of the worst years ever in financial markets, one of a very few across all asset classes to close in negative numbers.

Mark Twain once wrote, "History doesn’t repeat itself, but often rhymes."

2022 will be remembered as a challenging year financially. Unlike 2018, not all asset classes have been negative. Still, the two most important asset classes have been largely in the red. Last year will be remembered for the joint decline of the equity and bond markets after years of good results, albeit not without moments of strong swings, and not even instruments considered safe such as those under the U.S. Treasury have protected investors. 

Usually, the 60-40 stock/bond mix, the typical portfolio in the U.S., worked thanks to that bond component that cushioned the blows in the dark years for stocks. In 2022, however, this mix returned a deep red bottom line to investors.

Is there a light at the end of the tunnel? The answer is “yes,” because any crisis has not only a beginning but also an end. It will be the same this time too. 

However, despite having common features, crises are always different. What never changes are the gut reactions of savers who often, precisely at the moment of maximum pessimism, can no longer bear the volatility and give up by exiting their investments. 

In just a few months, the bond market has created, once again, interesting opportunities for those investors ready to seize them. The figure used in this article shows the growth in U.S. government bond yields from 2021 to September 2022.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Ethical issues in geriatric feline medicine

Like0
Dislike0

The future of canine glaucoma therapy

Like0
Dislike0

Impact of antibiotic use in the swine industry

Like0
Dislike0

WSU researchers join $9.6M push to fight Rift Valley fever

Like0
Dislike0

PetPace™ Launches World's First AI Smart Collar that Includes 24/7 Global Telehealth and Telemedicine—Revolutionizing Real-Time Health Monitoring for Dogs and Cats

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top